![](https://elearning.hesiglobal.org/sites/default/files/styles/course_image/public/course/2022-04/T%20cell%20targeting%20therapies%20%28e.g.%20activation%2C%20inhibition%20pathways%2C%20therapies%2C%20toxicities%29.png?itok=p1WJJEQT)
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities)
The "T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities)" course is 1 of 18 courses included in the Introduction to Immuno-Safety Science module.
This course is led by Dr. Courtni Newsome at Bristol Myers Squibb.
Learning Objectives
1. Basic T cell biology review |
2. Broad categories of T cell therapies and in what therapeutics areas they're most commonly used |
3. Types of toxicities with these therapies |
4. Future directions of these therapies? |